Soft pastels · Free shipping over $75 · Shop the boutique
Login Register
eccogene glp 1

eccogene glp 1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a GLP-1 receptor agonist for cardio-metabolic diseases AZD5004

SKU: 22976343859

4.8
USD29.69 USD53.69

Pay in 4 interest-free payments of $7.42 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 13 - Aug 18

Description

Looking to source GHK-Cu

eccogene glp 1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a GLP-1 receptor agonist for cardio-metabolic diseases AZD5004

Ipamorelin selectivity Raun et al., 1998 (Eur J Endocrinol): Ipamorelin produced GH release without elevating ACTH or cortisol, even at 200x the effective GH-releasing dose

eccogene glp 1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a GLP-1 receptor agonist for cardio-metabolic diseases AZD5004

doi:10.2165/00002018-200831100-00006

eccogene glp 1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a GLP-1 receptor agonist for cardio-metabolic diseases AZD5004

For many individuals, GLP-1 therapy can finally make weight loss feel achievable after years of frustration with restrictive diets and short-term solutions

eccogene glp 1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a GLP-1 receptor agonist for cardio-metabolic diseases AZD5004
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products